The Manufacturers Life Insurance Company increased its stake in LifePoint Health Inc (NASDAQ:LPNT) by 11.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,248 shares of the company’s stock after purchasing an additional 6,504 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in LifePoint Health were worth $3,249,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp increased its holdings in shares of LifePoint Health by 28.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock valued at $46,044,000 after purchasing an additional 177,329 shares in the last quarter. Convergence Investment Partners LLC purchased a new position in shares of LifePoint Health in the 3rd quarter valued at about $811,000. New York State Common Retirement Fund increased its holdings in shares of LifePoint Health by 3.2% in the 3rd quarter. New York State Common Retirement Fund now owns 84,969 shares of the company’s stock valued at $4,920,000 after purchasing an additional 2,669 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of LifePoint Health by 26.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 132,589 shares of the company’s stock valued at $7,757,000 after purchasing an additional 27,726 shares in the last quarter. Finally, Boston Partners increased its holdings in shares of LifePoint Health by 50.8% in the 4th quarter. Boston Partners now owns 874,690 shares of the company’s stock valued at $43,559,000 after purchasing an additional 294,480 shares in the last quarter.
LPNT has been the subject of a number of research analyst reports. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Morgan Stanley restated an “equal weight” rating and set a $46.00 target price (down from $50.00) on shares of LifePoint Health in a report on Monday, February 26th. SunTrust Banks dropped their target price on shares of LifePoint Health to $44.00 and set a “hold” rating for the company in a report on Monday, February 26th. ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Finally, Zacks Investment Research upgraded shares of LifePoint Health from a “strong sell” rating to a “hold” rating in a report on Monday, January 22nd. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $55.00.
LifePoint Health (NASDAQ:LPNT) last released its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.04). LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the business posted $1.07 earnings per share. LifePoint Health’s revenue was down 7.2% on a year-over-year basis. analysts anticipate that LifePoint Health Inc will post 4.27 EPS for the current fiscal year.
In related news, insider David M. Dill sold 45,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the sale, the insider now directly owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman William F. Carpenter III bought 21,368 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was bought at an average cost of $46.80 per share, for a total transaction of $1,000,022.40. Following the completion of the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. 8.76% of the stock is currently owned by company insiders.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.